BOSTON CONDITIONING SOLUTION

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2016-11-23 for BOSTON CONDITIONING SOLUTION manufactured by Bausch & Lomb Incorporated.

Event Text Entries

[60845911] The complaint sample was returned for evaluation and the results of the chemical testing performed were consistent with shelf life limits. Bioburden testing shows a growth identified as paenibacillus sp. Paenibacillus agarivorans (b)(4) was found on the outside of the bottle tip and inside of the cap. There was insufficient sample to perform complete biomedical testing. The testing that were performed were within required specifications. Doctor reported patient's eyelid and skin flares with high pollen season and a history of azelastine eye drops. The doctor cannot determined if the event is related to a specific product. Based on available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


[60845912] Consumer reported visiting an allergist for pain in his right eye. Before visiting office, the consumer self-treated with vanicream, desonide cream, pazeo, and ketotifen. Medical information from the allergist indicated patient has a history of perennial allergies and a history of treatment with azelastine (antihistamine) eye drops. The allergist reported the patient's eyelids and skin flare with high pollen season. Office states that patient was seen for inflammation, swelling and redness on the right eye. Doctor diagnosed patient with allergic conjunctivitis. Doctor instructed patient to use tobradex for three days and discontinue contact lens wear. The allergist was unable to determine if the event was related to a specific product. The consumer provided follow-up information that indicated his eye recovered after tobradex use. The consumer reported that when his eye recovered he began wearing his lenses again and also used the lens care product. Patient reported reoccurrence of symptoms and that he has continued to wear his lenses. The consumer has not returned to a health care provider at the time of this report.
Patient Sequence No: 1, Text Type: D, B5


[62396974] A review of the lot batch record and testing of a retain sample concluded this product was formulated, manufactured and packaged according to local and global specifications. Based on available information, no causal factors can be determined and no conclusion can be drawn.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number0001313525-2016-00668
MDR Report Key6125232
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2016-11-23
Date of Report2016-09-07
Date of Event2016-09-07
Date Mfgr Received2016-12-05
Device Manufacturer Date2016-03-06
Date Added to Maude2016-11-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SHARON SPENCER
Manufacturer Street50 TECHNOLOGY DRIVE WEST
Manufacturer CityIRVINE CA 92618
Manufacturer CountryUS
Manufacturer Postal92618
Manufacturer Phone9493985698
Manufacturer G1BAUSCH + LOMB
Manufacturer Street8507 PELHAM ROAD
Manufacturer CityGREENVILLE SC 29615
Manufacturer CountryUS
Manufacturer Postal Code29615
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBOSTON CONDITIONING SOLUTION
Generic NamePRODUCTS, CONTACT LENS CARE, RIGID GAS PERMEABLE
Product CodeMRC
Date Received2016-11-23
Returned To Mfg2016-10-07
Lot NumberGC16005
ID NumberNI
Device Expiration Date2018-03-31
OperatorLAY USER/PATIENT
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBAUSCH & LOMB INCORPORATED
Manufacturer Address1400 NORTH GOODMAN STREET ROCHESTER NY 14609 US 14609


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-11-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.